Melanie Proven

Melanie is the Principal Clinical Scientist leading the haemoglobinopathy and rare anaemias team at the National Haemoglobinopathies Reference Laboratory. Following her PhD in Genetics at Cambridge, she began working as a Clinical Scientist in the Oxford Regional Genomics Laboratory in 2004, specialising in haematological inherited disorders from 2014. She forms the core of the Sickle Cell and Thalassaemia Support Service, in combination with colleagues Jenny Eglinton and Michelle Rugless, who have both worked in haemoglobinopathies for over a decade.

Is elevated fetal haemoglobin a cause for concern in antenatal screening?

Melanie Proven, 31 May 2019 - NHS Sickle Cell and Thalassaemia Screening Programme

The sickle cell and thalassaemia screening support service provides advice on when antenatal screening results involving a raised level of Hb F, the fetal version of haemoglobin, should be followed up.

The PHE Screening team

Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.

Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.

If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.

Categories

Useful links

• Screening helpdesk
• Introduction to population screening e-learning
• Professional information (GOV.UK)
• Public information (NHS.UK)
• Simple PDF leaflets for printing
• Screening QA Service (SQAS)
• Education and training
• UK National Screening Committee

Blog tags

accessible information (116) Annual call (2) annual reports and updates (42) antenatal screening (165) artificial intelligence (4) blog news (20) call and recall (1) consultations (20) Coronavirus recovery (6) CPD and qualifications (74) data and KPIs (69) diagnostic testing (10) digital invitations (40) e-learning (31) easy read information (2) events and courses (77) failsafe (20) FIT (7) helpdesk (8) HPV (24) incidents (9) inequalities (97) information governance (6) IT systems (41) laboratories (32) monthly roundup (36) newborn screening (157) NIPT (19) primary care (15) public information and informed choice (148) quality improvement (98) research and audit (40) SCID (8) screening benefits and risks (38) shared learning (112) standards (47) STFYAYB (2) views from the front line (68) vision screening (5) workforce (46)

Comments and moderation

Read our guidelines

Recent posts

• Changes ahead for the national screening system 30 September 2021
• What we blogged about in August and September 2021 30 September 2021
• New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021

Follow us on social media

• PHE Screening on Twitter